Activity Overview

This educational activity is an archive of the live conference held on January 24, 2026.

Target Audience

This educational activity is directed toward medical oncologists and practitioners of oncology subspecialties, along with surgeons, radiologists, general scientists, young investigators, nurses, and pharmacists with an interest in lung cancer. Other health care professionals interested in the treatment of lung cancer are also invited to participate.

Learning Objective

Integrate emerging clinical trial evidence regarding the management of patients with lung cancer into personalized treatment plans

David R. Gandara, MD

Professor of Medicine Emeritus
Co-Director, Center for Experimental Therapeutics in Cancer
Senior Advisor to the Director
UC Davis Comprehensive Cancer Center
Adjunct Clinical Professor, Translational and Clinical Research Program
University of Hawaii Cancer Center
Chief Medical Officer, International Society of Liquid Biopsy
Sacramento, CA

Sarah Goldberg, MD, MPH

Professor of Internal Medicine
Co-Director, Center for Thoracic Cancers
Chief, Thoracic Oncology
Yale School of Medicine
New Haven, CT

Tamie Kerns, DO

Hematologist-Oncologist
Kaiser Permanente
Honolulu, HI

Suma Reddy-Satti, MD

Vice Chair, Hematology/Oncology
St Tammany Cancer Center
Medical Oncologist
Ochsner Health
New Orleans, LA

Jonathan W. Riess, MD, MS

Associate Professor of Medicine
Director, Thoracic Oncology
UC Davis Comprehensive Cancer Center
Sacramento, CA

Nicolas Villanueva, MD

Assistant Clinical Professor
Department of Medicine
John A. Burns School of Medicine
University of Hawaiʻi at Mānoa
Clinical Faculty
University of Hawai‘i Cancer Center
Hematology/Oncology
Hawaii Oncology, Inc
Honolulu, HI

Ricardo Blanco, MD

Pulmonologist
St Tammany Health System
Covington, LA

Anne Chiang, MD, PhD

Associate Professor, Section of Thoracic Oncology
Yale School of Medicine
Associate Cancer Center Director, Clinical Initiatives
Yale Cancer Center
New Haven, CT

Taryne A. Imai, MD, MEHP, FACS

Director, Thoracic Surgery
The Queen’s Health Systems
Honolulu, HI

Joel W. Neal, MD, PhD

Professor of Medicine, Oncology
Stanford University
Palo Alto, CA

William Loui, MD, FACP

Medical Oncologist
Adventist Health Castle
Kailua, HI

Melvin Palalay, MD

Medical Oncologist
University of Hawai‘i Cancer Center
Honolulu, HI

Ashley Springer, MSN, AGPCNP-BC, APRN-Rx

Assistant Professor
University of Hawaiʻi Cancer Center
University of Hawai‘i at Mānoa
Honolulu, HI

Nicholas Stollenwerk, MD

Health Sciences Clinical Professor, UC Davis Health
Pulmonary and Critical Care Medicine
Interventional Pulmonology
UC Davis Comprehensive Cancer Center
Sacramento, CA

GET STARTED WITH THIS PROGRAM:

Create Account Already Registered? Login Here

Accreditation/Credit Designation

Physicians’ Education Resource^®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource^®, LLC designates this enduring material for a maximum of 1.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource^®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 1.75 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by educational grants from AstraZeneca Pharmaceuticals, Inc; Daiichi Sankyo, Inc; and Merck Sharp & Dohme, LLC.

Module 2: Oncogene-Driven mNSCLC